Prestige Biologics Co., Ltd is a biopharmaceutical CMO, CDMO, CDEMO (Contract Development Engineering Manufacturing Organization) that provides complete solutions to the development and manufacturing requirements in your drug discovery from early stage to product registration and commercialization. Based on our fully established antibody drug & vaccine manufacturing capabilities, we now offer our upgraded CDMO service, CDEMO in which we provide customized engineering solutions for your manufacturing process in a customized manufacturing suite speed-built with our proprietary technology, ALITA Smart BioFactory™.
Company Details
- Employees
- 19
- Founded
- -
- Address
- 청주시 흥덕구 오송읍 오송생명1로 197, 프레스티지바이오로직스 제1캠퍼스,korea, Republic Of
- Phone
- +82.43.232.1552
- in****@****a.co.kr
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- pbpharma.co.kr
- HQ
- 청주시, 충청북도
Prestige Biologics - Cdmo Questions
Prestige Biologics - Cdmo's helpline number is +82.43.232.1552
Prestige Biologics - Cdmo's website is pbpharma.co.kr
Prestige Biologics - Cdmo's LinkedIn profile is https://kr.linkedin.com/company/prestige-biologics-co-ltd
Prestige Biologics - Cdmo has
19 employees.
View email and phone details for 19
employees at Prestige Biologics - Cdmo.
Prestige Biologics - Cdmo's industry is
Pharmaceutical Manufacturing
Prestige Biologics - Cdmo's top competitors are
Business Development Consultancy (Cdmo),
Yuhan Corporation,
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics),
Celltrion Inc,
Cellvec Pte Ltd,
Hummingbird Bioscience,
Tessa Therapeutics Ltd,
Yuhan Cdmo,
Tanvex Cdmo Is Now Bora Biologics,
Cdmo Advisor.
Prestige Biologics - Cdmo's support email address is info@pbpharma.co.kr
Prestige Biologics - Cdmo's categories are Pharmaceutical Manufacturing
Prestige Biologics - Cdmo's founding year is 2015
